Francesco Ceci
University of Turin
Internal medicineRadiologyUrologyPET-CTOncologyStage (cooking)Positron emission tomographyBiopsyBiochemical recurrenceProstatectomyProstate cancerLymph nodeRecurrent prostate cancer68Ga-PSMA-11Nuclear medicineIn patientPsma pet ct11c choline pet ct68ga psmaRadiation therapyMedicine
Publications 104
#1Guido Rovera (UCSC: Catholic University of the Sacred Heart)
#2Daniela E. Oprea-Lager (VUmc: VU University Medical Center)H-Index: 14
Last. Francesco Ceci (IEO: European Institute of Oncology)H-Index: 24
view all 0 authors...
To summarize recent analyses on the economic aspects regarding the use of PSMA-PET in prostate cancer and to evaluate the cost-effective management of patients referred to this new generation imaging to stage the disease. A comprehensive search was performed based on SCOPUS and PubMed databases to evaluate studies reporting about cost analysis in PSMA-PET. Preliminary data regarding the cost-effective management of prostate cancer patients investigated with PSMA-PET have been found. These studie...
#1Riccardo Laudicella (UNIME: University of Messina)H-Index: 8
#2Natale QuartuccioH-Index: 14
Last. Andrei Iagaru (Stanford University)H-Index: 37
view all 14 authors...
PURPOSE The objective of this review was to explore the potential clinical application of unconventional non-amino acid PET radiopharmaceuticals in patients with gliomas. METHODS A comprehensive search strategy was used based on SCOPUS and PubMed databases using the following string: ("perfusion" OR "angiogenesis" OR "hypoxia" OR "neuroinflammation" OR proliferation OR invasiveness) AND ("brain tumor" OR "glioma") AND ("Positron Emission Tomography" OR PET). From all studies published in English...
#2Cinzia RomagnoloH-Index: 1
Last. Luca BurroniH-Index: 1
view all 8 authors...
Background: to explore the diagnostic accuracy of 18F-Fluciclovine positron-emission tomography (PET) in prostate cancer (PCa), considering both primary staging prior to radical therapy, biochemical recurrence, and advanced setting. Methods: A systematic web search through Embase and Medline was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. Studies performed from 2011 to 2020 were evaluated. The terms used were “PET” or “positr...
#1Giulia Polverari (UNIBO: University of Bologna)H-Index: 6
#2Francesco Ceci (UNITO: University of Turin)H-Index: 24
Last. Noah Federman (UCLA: University of California, Los Angeles)H-Index: 27
view all 13 authors...
This is a prospective, single-center trial in pediatric patients with sarcoma aiming to evaluate [18F]FDG PET/CT as a tool for early response assessment to neoadjuvant chemotherapy (neo-CTX). Bone or soft tissue sarcoma patients with (1) baseline [18F]FDG PET/CT within 4 weeks prior to the start of neo-CTX (PET1), (2) early interim [18F]FDG PET/CT (6 weeks after the start of neo-CTX (PET2), (3) evaluation of neo-CTX response by histology or MRI, and (4) definitive therapy after neo-CTX (surgery ...
1 CitationsSource
#1Pierpaolo AlongiH-Index: 14
#2Riccardo Laudicella (UNIME: University of Messina)H-Index: 8
Last. Giorgio Ivan Russo (National Research Council)H-Index: 33
view all 16 authors...
BACKGROUND Radiomic features are increasingly utilized to evaluate tumor heterogeneity in PET imaging but to date its role has not been investigated for Cho-PET in prostate cancer. The potential application of radiomics features analysis using a machine-learning radiomics algorithm was evaluated to select 18F-Cho PET/CT imaging features to predict disease progression in PCa. METHODS We retrospectively analyzed high-risk PCa patients who underwent restaging 18F-Cho PET/CT from November 2013 to Ma...
1 CitationsSource
#1Emanuela Pilati (UNITO: University of Turin)H-Index: 1
Last. Désirée DeandreisH-Index: 30
view all 9 authors...
Prostate-specific membrane antigen (PSMA) is a transmembrane enzyme also known as folate hydrolase 1 highly expressed by prostate cancer (PCa) cells. However, PSMA overexpression by tumor-associated neovasculature of a variety of solid tumors, including glioblastoma (GBM), has also been proven. This clinical case reports about a 67-year-old man with a history of PCa who underwent radical surgery for GBM and performed a Ga-PSMA-11 PET/CT to restage PCa. PET imaging showed PSMA uptake in GBM resid...
#1Lorenzo Bianchi (UNIBO: University of Bologna)H-Index: 13
#2Marco Borghesi (UNIBO: University of Bologna)H-Index: 26
Last. Francesco Ceci (UNIBO: University of Bologna)H-Index: 24
view all 11 authors...
To perform an external validation of a recently published nomogram aimed to predict positive 68Ga-PSMA-11 PET/CT in patients with biochemical recurrence (BCR) after radical prostatectomy (RP) by Rauscher et al. (Eur Urol 73(5):656–661, 2018). Overall, 413 PCa patients with BCR after RP (two consecutive PSA ≥ 0.2 ng/ml) and PSA value between 0.2 and 1 ng/ml were included. A multivariable logistic regression model was produced to assess the predictors of positive 68Ga-PSMA-11 PET/CT results. The p...
5 CitationsSource
#1Francesco Ceci (UNIBO: University of Bologna)H-Index: 24
#2Lorenzo Bianchi (UNIBO: University of Bologna)H-Index: 13
Last. Stefano Fanti (UNIBO: University of Bologna)H-Index: 83
view all 10 authors...
Objective The objective of this study was to develop a clinical nomogram to predict gallium-68 prostate-specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA-11-PET/CT) positivity in different clinical settings of PSA failure.
16 CitationsSource
#1Andrei FodorH-Index: 10
#1Andrei FodorH-Index: 13
Last. Gianluca IngrossoH-Index: 13
view all 11 authors...
Purpose Oligorecurrent prostate cancer with exclusive nodal involvement represents a common state of disease, amenable to local therapy. New radio-labeled tracers have enriched the possibility of cancer detection and treatment. In this review, we aim to illustrate the main nuclear medicine diagnostic options and the role of radiotherapy in this setting of patients.
7 CitationsSource
#1Jeremie Calais (UCLA: University of California, Los Angeles)H-Index: 20
#2Francesco Ceci (UNITO: University of Turin)H-Index: 24
Last. Johannes Czernin (UCLA: University of California, Los Angeles)H-Index: 94
view all 9 authors...
3 CitationsSource